Senior Organization Development Manager at Legend Biotech

Franklin Township, New Jersey, United States

Legend Biotech Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Bachelor's degree in human resources, organizational development, business, psychology, or a related field; Master's degree preferred
  • 10+ years of experience in organizational development, leadership management, culture development, with a proven track record of global or multi-region involvement
  • Strong understanding of organizational development theory, practices, and industry trends, working experience as a consultant is preferred
  • Strong business acumen and in-depth understanding of the pharmaceutical and biotech industries
  • Exceptional communication and interpersonal skills, including English language proficiency; additional fluency in Mandarin or Dutch languages preferred
  • Strong project management skills, managing multiple projects simultaneously
  • Adaptable to the fast-paced culture and environment of the biotech industry

Responsibilities

  • Develop and implement organization development strategies and policies that align with company strategy and business goals, ensuring consistent practices across multiple regions and business units
  • Collaborate with the leadership team to design and execute an organizational structure that supports the company's long-term and short-term strategic plans
  • Manage and implement "strategy-to-execution" system that empowers the company to attain its strategic goals, including strategy meetings design, setting and monitoring departmental goals, evaluating departmental performance etc
  • Collaborate with HR to develop leadership management strategies that identify, evaluate, develop and retain leaders and build a strong leadership pipeline, living corporate cultures and values in Leadership team
  • Lead change management initiatives, ensuring effective communication to all stakeholders, considering cultural and language considerations across regions
  • Implement and maintain organizational development metrics, providing organizational diagnosis to improve effectiveness as needed
  • Stay informed about industry best practices and trends in organizational development and leadership management, incorporating them into company programs and processes

Skills

Organization Development
Organizational Design
Leadership Development
Change Management
Strategic Planning
HR Strategy

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters
2014Year Founded
$146.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Sick Leave
Paid Holidays
Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI